- Home
- UPST vs KRYS Comparison
UPST vs KRYS Comparison
Compare UPST & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPST
- KRYS
- Stock Information
- Founded
- UPST 2012
- KRYS 2015
- Country
- UPST United States
- KRYS United States
- Employees
- UPST N/A
- KRYS N/A
- Industry
- UPST Finance: Consumer Services
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UPST Finance
- KRYS Health Care
- Exchange
- UPST Nasdaq
- KRYS Nasdaq
- Market Cap
- UPST 4.8B
- KRYS 4.7B
- IPO Year
- UPST 2020
- KRYS 2017
- Fundamental
- Price
- UPST $52.72
- KRYS $185.85
- Analyst Decision
- UPST Buy
- KRYS Strong Buy
- Analyst Count
- UPST 14
- KRYS 9
- Target Price
- UPST $74.73
- KRYS $210.22
- AVG Volume (30 Days)
- UPST 7.3M
- KRYS 277.9K
- Earning Date
- UPST 11-04-2025
- KRYS 11-03-2025
- Dividend Yield
- UPST N/A
- KRYS N/A
- EPS Growth
- UPST N/A
- KRYS 36.22
- EPS
- UPST N/A
- KRYS 4.91
- Revenue
- UPST $884,807,000.00
- KRYS $359,205,000.00
- Revenue This Year
- UPST $59.39
- KRYS $34.33
- Revenue Next Year
- UPST $27.34
- KRYS $47.84
- P/E Ratio
- UPST N/A
- KRYS $37.95
- Revenue Growth
- UPST 53.62
- KRYS 116.08
- 52 Week Low
- UPST $31.40
- KRYS $122.80
- 52 Week High
- UPST $96.43
- KRYS $207.84
- Technical
- Relative Strength Index (RSI)
- UPST 46.26
- KRYS 58.02
- Support Level
- UPST $48.00
- KRYS $183.03
- Resistance Level
- UPST $53.44
- KRYS $196.78
- Average True Range (ATR)
- UPST 3.02
- KRYS 6.47
- MACD
- UPST 0.82
- KRYS -1.28
- Stochastic Oscillator
- UPST 71.33
- KRYS 37.84
About UPST Upstart Holdings Inc.
Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. Upstart's platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small-dollar loans.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.